Multidimensional Assessment of Fall Risk Using the Timed Up and Go Test and Complementary Measures in a Charcot-Marie-Tooth Type 1A Neuropathy

Read full text
Authors: Héloïse Ferrandon-Berne, Mathilde Pelletier Visa, Lech Dobija, Maxime Grolier, Frédéric Costes, Frédéric Taithe, Vivien Reynaud, Bruno Pereira, Emmanuel Coudeyre
Cited by: 0
References: 25

Abstract

Objective: To investigate the relationship between the occurrence of falls and the time taken to perform the Timed Up and Go (TUG) test in a population of patients with Charcot-Marie-Tooth disease type 1A (CMT1A). Design: We conducted a longitudinal, single-center, exploratory study involving adult patients with CMT1A, followed for 1 year. Physical, functional, and analytical tests, including the TUG test, gait analysis, and muscle strength assessment, were performed at baseline, 6 months, and 12 months. Patients also completed questionnaires on physical capabilities, fatigue, falls, and the impact on quality of life and psychological health. The study was conducted between September 2020 and February 2025. Setting: This study was conducted at a university hospital. Participants: Patients (n=40) included in this study had to be adults, have a molecular biology-confirmed diagnosis of CMT1A, have quadriceps strength >2 of 5, and have a proficient oral and written understanding of French. Interventions: Not applicable. Main outcome measures: The primary outcome was the time (in s) required to complete the TUG test, analyzed according to the frequency of self-reported falls. Secondary outcome measures included balance performance assessed with the Berg Balance Scale (BBS) and walking endurance evaluated by the distance covered during the 6-minute walk test (6MWT). Physical, functional, and analytical tests were conducted at baseline, 6 months, and 12 months. Results: =.710). Median BBS and 6MWT values at baseline were 52 (47-55) and 422 (335-480) m, respectively, showing no significant change after 1 year of follow-up. Conclusions: When used alone, the TUG test is not a suitable tool for fall risk screening in patients with CMT1A. Balance (BBS) and walking endurance (6MWT) also remained stable over 1 year. Global assessment is crucial for detecting physical impairments and preventing falls. A future study could include a larger sample and a more precise categorization of falls.

Fields of Study & Subjects

Hereditary Neurological Disorders Peripheral Neuropathies and Disorders Amyotrophic Lateral Sclerosis Research

Publication details

Journal / source
Archives of Rehabilitation Research and Clinical Translation
Volume
8
Issue
2
Pages
100581–100581
Publication date
1 January 2026
Language
EN